Che Ping Cheng | Translational Neuroscience | Best Researcher Award

Posted on 02/05/2025 by Neuroscientists

Prof. Che Ping Cheng | Translational Neuroscience | Best Researcher Award

Prof. Che Ping Cheng, Wake Forest University School of Medicine, United States.

Dr. Che Ping Cheng, M.D., Ph.D., FAHA, is a distinguished cardiovascular physiologist and internal medicine specialist whose career has been dedicated to advancing the understanding of heart function and failure. From earning his medical degree in China to completing a Ph.D. in Physiology at Wayne State University, and later conducting pivotal postdoctoral research at Wake Forest School of Medicine, Dr. Cheng has consistently pursued excellence in science and education. His research on ventricular mechanics, volume loading, and heart failure has significantly influenced both experimental cardiology and clinical practice. Recognized as a Fellow of the American Heart Association, he is also a dedicated mentor, shaping the next generation of cardiovascular researchers through his academic leadership.

Profile

Scopus

🎓 Early Academic Pursuits

Dr. Che Ping Cheng’s journey into medicine and science began in Nanjing, China, where he earned his M.D. degree from Nanjing Railway Medical University in 1977. His early academic path reflected a deep interest in understanding the intricacies of human health, particularly in cardiovascular physiology. Driven by a desire to expand his knowledge and research capabilities, Dr. Cheng pursued his Ph.D. in Physiology at Wayne State University School of Medicine in Detroit, Michigan, completing his degree in 1986. Under the mentorship of Dr. Robert S. Shepard, his doctoral work focused on exploring the mechanisms of cardiovascular response to volume loading in a canine model with tricuspid valvulectomy, setting a strong foundation for his lifelong focus on heart function and disease mechanisms.

🩺 Professional Endeavors

Following his academic training, Dr. Cheng embarked on postdoctoral studies at the Bowman Gray School of Medicine (now part of Wake Forest School of Medicine), where he continued to cultivate his expertise in internal medicine and cardiovascular physiology. Between 1986 and 1988, he served as a Postdoctoral Fellow under the guidance of Dr. William C. Little. His research during this period focused on ventricular dynamics and the physiological factors affecting active ventricular filling, which would later inform his broader work on heart failure and cardiac function. Dr. Cheng has since remained at Wake Forest School of Medicine, where he is currently a distinguished member of the Section on Cardiovascular Medicine.

🧪 Contributions and Research Focus

Dr. Cheng’s career has been characterized by a deep commitment to advancing the understanding of cardiac hemodynamics, ventricular interaction, and heart failure mechanisms. His research has explored how ventricular function responds under altered physiological states, and how these responses inform disease progression and treatment strategies. His early animal model studies have provided critical insights into the interplay between structural and functional changes in the heart, especially in the context of diastolic dysfunction and volume overload conditions. Dr. Cheng has also made significant strides in translating these findings to clinical contexts, influencing how cardiologists approach diagnosis and therapy.

🏅 Accolades and Recognition

Throughout his career, Dr. Cheng has received considerable recognition for his scholarly contributions. He is a Fellow of the American Heart Association (FAHA), an honor that reflects his standing in the field of cardiovascular research and his commitment to scientific excellence. His work has earned the respect of colleagues and institutions alike, leading to numerous invitations to contribute to collaborative projects, serve on peer-review panels, and mentor future generations of cardiovascular researchers.

🌍 Impact and Influence

Dr. Cheng’s work has had a lasting impact on both experimental and clinical cardiology. By elucidating the mechanistic basis of ventricular dysfunction, he has helped shift paradigms in heart failure management, particularly in the areas of ventricular interdependence and preload responsiveness. His research findings are frequently cited in textbooks and high-impact journals, and they continue to inform guidelines for cardiac care and interventions. Through his work at Wake Forest and beyond, Dr. Cheng has played a pivotal role in bridging laboratory discoveries with bedside applications.

👨‍🏫 Legacy and Mentorship

As a respected mentor and educator, Dr. Cheng has dedicated a significant portion of his career to training medical students, residents, and postdoctoral fellows. His mentorship has influenced numerous emerging scholars in cardiovascular medicine, many of whom have gone on to successful academic and clinical careers. His guidance combines a rigorous scientific approach with a deep sense of responsibility to patient care and scientific integrity, shaping a legacy that extends well beyond his own research output.

🔬 Future Contributions and Vision

Looking ahead, Dr. Cheng remains committed to the advancement of cardiovascular research, with a continued focus on uncovering the cellular and mechanical determinants of heart disease. His vision includes fostering collaborative projects that integrate biomedical engineering, imaging, and computational modeling to further understand cardiac performance. With decades of experience and a forward-thinking approach, Dr. Cheng’s future contributions are poised to leave a lasting mark on the field of translational cardiovascular medicine.

Publication

Title: Increased CaMKII activation and contrast changes of cardiac β1-and β3-Adrenergic signaling pathways in a humanized angiotensinogen model of hypertension
Authors: Sun, Xiaoqiang; Cao, Jing; Chen, Zhe; Ferrario, Carlos M.; Cheng, Cheping
Year: 2023
Journal: Heliyon

Title: Calmodulin-dependent protein kinase II activation promotes kidney mesangial expansion in streptozotocin-induced diabetic mice
Authors: Mikhailov, Alexei V.; Liu, Yixi; Cheng, Hengjie; Lin, Jen Jar; Cheng, Cheping
Year: 2022
Journal: Heliyon

Title: Chronic GPR30 agonist therapy causes restoration of normal cardiac functional performance in a male mouse model of progressive heart failure: Insights into cellular mechanisms
Authors: Zhang, Xiaowei; Li, Tiankai; Cheng, Hengjie; Groban, Leanne; Cheng, Cheping
Year: 2021
Journal: Life Sciences

Title: Chronic Ca2+/calmodulin-dependent protein Kinase II inhibition rescues advanced heart failure
Authors: Liu, Yixi; Shao, Qun; Cheng, Hengjie; Zhao, David Xiao Ming; Cheng, Cheping
Year: 2021
Journal: Journal of Pharmacology and Experimental Therapeutics

Title: The Angiotensin-(1–12)/Chymase axis as an alternate component of the tissue renin angiotensin system
Authors: Ferrario, Carlos M.; Groban, Leanne; Wang, Hao; Sun, Xuming; Ahmad, Sarfaraz
Year: 2021
Journal: Molecular and Cellular Endocrinology

Title: Reversal of angiotensin-(1–12)-caused positive modulation on left ventricular contractile performance in heart failure: Assessment by pressure-volume analysis
Authors: Li, Tiankai; Zhang, Zhi; Zhang, Xiaowei; Ferrario, Carlos M.; Cheng, Cheping
Year: 2020
Journal: International Journal of Cardiology

Title: Female Heart Health: Is GPER the Missing Link?
Authors: Groban, Leanne; Tran, Q. K.; Ferrario, Carlos M.; Wang, Hao; Lindsey, Sarah H.
Year: (Not specified, but likely 2020 or 2021)
Journal: (Not specified)

🏁 Conclusion

Dr. Cheng’s legacy is one of intellectual rigor, clinical relevance, and mentorship. His work has not only deepened the scientific understanding of cardiac physiology but has also shaped modern approaches to diagnosing and managing heart failure. With a career spanning continents and disciplines, Dr. Cheng continues to be a guiding force in cardiovascular medicine, and his future contributions are anticipated to further advance the frontiers of heart research and patient care.

Atena Shojaie | Behavioral Neuroscience | Best Researcher Award

Posted on 30/04/2025 by Neuroscientists

Ms. Atena Shojaie | Behavioral Neuroscience | Best Researcher Award

Ms. Atena Shojaie, Kerman university of medical sciences, Iran.

Atena Shojaie is a dedicated medical-surgical nursing professional with a Master’s degree from Kerman University of Medical Sciences. Her early academic journey was marked by a passion for integrating clinical care with research, particularly in neurology and rehabilitation. Over three years of working in critical care settings, including Neurology and ICU wards, she honed her clinical expertise while also serving as a valued clinical instructor. Her research focus on guided imagery as a therapeutic intervention for multiple sclerosis and MRI-induced anxiety has led to innovative practices currently in use at major hospitals. Atena’s academic contributions are beginning to gain recognition through citations and clinical adoption of her methods.

Profile

Google Scholar

🎓 Early Academic Pursuits

Atena Shojaie began her journey in the field of healthcare with a strong academic foundation, earning a bachelor’s degree in nursing followed by a Master of Science in Medical-Surgical Nursing from Kerman University of Medical Sciences. Her early academic interests revolved around holistic patient care and neuro-rehabilitation, which laid the groundwork for her later clinical and research endeavors. During her postgraduate studies, she demonstrated a deep commitment to understanding patient needs—especially those facing neurological challenges—while also refining her clinical skills in hospital environments.

🏥 Professional Endeavors

In the span of just three years, Atena accumulated extensive experience working in several critical hospital wards, including Neurology, Neurosurgery, and the Intensive Care Unit (ICU). Her hands-on experience with acute and chronic conditions shaped her clinical intuition and enhanced her ability to manage complex patient cases. Parallel to her clinical work, she embraced the role of a clinical instructor, mentoring nursing and emergency medical students with a balance of academic rigor and compassionate teaching. This dual role of caregiver and educator reflects her deep-seated dedication to both practice and pedagogy.

🔬 Contributions and Research Focus

Atena’s research primarily centers on the intersection of psychological interventions and physical rehabilitation, with a particular emphasis on multiple sclerosis (MS). Her master’s thesis, “The Effectiveness of Guided Imagery on Walking and Balance Dysfunction in Patients With Multiple Sclerosis,” stands as a cornerstone of her academic work. The project demonstrated measurable improvements in gait and balance among MS patients and has since influenced ongoing clinical practices. Additionally, she completed a significant study on the “Anxiety of Patients Undergoing Magnetic Resonance Imaging (MRI),” showing how guided imagery can alleviate pre-procedure stress—further reflecting her commitment to patient-centered innovations.

🧠 Innovations in Mental Imagery

Atena Shojaie has been instrumental in translating academic research into practical tools for patient care. One of her notable innovations includes the creation of a guided imagery audio file, which is now regularly used in two major healthcare centers—Bahonar Hospital’s MRI department and Shafa Hospital’s MS Clinic. This therapeutic tool has not only improved the mental well-being of patients but also contributed to smoother clinical workflows, particularly in high-anxiety environments like radiology units.

📈 Impact and Influence

Although still early in her research career, Atena’s work has begun to gain scholarly recognition. With a citation index that includes three citations and an h-index of 1, her research is already laying the foundation for future studies in neuro-nursing and psychological rehabilitation. Her work continues to resonate with clinical teams and academics alike, especially those focused on non-pharmacological interventions for neurological conditions.

🏅 Accolades and Recognition

Atena’s clinical and research activities have earned her respect among her peers and mentors at Kerman University of Medical Sciences. While formal awards may still be on the horizon, her true recognition lies in the adoption of her guided imagery methods by major hospitals—an endorsement of both her scientific rigor and clinical insight. Her role as a trusted clinical instructor further affirms her reputation as a knowledgeable and compassionate professional.

🌟 Legacy and Future Contributions

With a solid foundation in research and hands-on care, Atena Shojaie is poised to make enduring contributions to the field of neuro-rehabilitative nursing. Her vision includes expanding the use of therapeutic mental imagery in broader hospital settings and conducting multi-center studies to further validate its effectiveness. As she continues her academic and clinical journey, her legacy will likely be defined by a thoughtful fusion of science, compassion, and innovation—paving the way for future advancements in holistic patient care.

Publication

Anxiety of Patients Undergoing Magnetic Resonance Imaging (MRI): The Effectiveness of Guided Mental Imagery
Authors: A. Shojaie, H. Amiri, T. Dehesh, B. Bagherian
Year: 2024

The Effectiveness of Guided Imagery on Walking and Balance Dysfunction in Patients With Multiple Sclerosis: A Randomized Controlled Trial
Authors: B.B. Atena Shojaie, Hoda Kamali, Monir Sadat Nematollahi, Zahra Imani Goghary
Year: 2025

✅ Conclusion

Atena Shojaie exemplifies the new generation of nurse-researchers who bridge the gap between evidence-based practice and compassionate patient care. Her work in guided mental imagery not only addresses physical dysfunction but also supports patients’ emotional and psychological needs. As she continues to expand her research and clinical impact, Atena is well-positioned to influence future standards in neuro-nursing and non-pharmacological therapy. Her legacy will likely be defined by innovation, empathy, and a relentless pursuit of better outcomes for patients with neurological conditions.

CARMINA MONTOLIU | Clinical Neuroscience | Best Researcher Award

Posted on 26/04/2025 by Neuroscientists

Prof. Dr. CARMINA MONTOLIU | Clinical Neuroscience | Best Researcher Award

Prof. Dr. CARMINA MONTOLIU, UNIVERSIDAD DE VALENCIA/INCLIVA, Spain.

Carmina Montoliu Felix, a Valencia-born scientist and educator, is a distinguished Catedrática de Universidad at the Universidad de Valencia, specializing in Cellular Biology and Pathology. With a strong foundation in biomedical sciences and a dual role in both academia and clinical research through INCLIVA, she has become a key figure in translational medicine in Spain. Her work focuses on uncovering cellular mechanisms of disease, supported by national recognition such as her Group A classification by ISCIII. With extensive contributions indexed on platforms like ORCID and Scopus, she has gained international visibility and continues to influence the fields of pathology and biomedicine.

Profile

Orcid

🎓 Early Academic Pursuits

Carmina Montoliu Felix was born in Valencia, where she also pursued her academic career rooted in the life sciences. Her early interest in biology and medical sciences led her through a rigorous academic pathway that would eventually shape her into a leading figure in cellular pathology. With a profound dedication to understanding human disease at the cellular level, she cultivated a strong foundation in biology, which became the cornerstone of her future specialization in Cellular Biology and Pathology. These formative years instilled in her a passion for translational research, which continues to drive her work.

🏛️ Professional Endeavors

Currently serving as a Catedrática de Universidad at the Facultad de Medicina y Odontología of the Universidad de Valencia, Carmina Montoliu Felix holds a prestigious position within the Departamento de Patología, specifically in the Unidad de Biología. She achieved this distinguished academic rank on November 3, 2023, under BOE nº 274, a recognition of her academic excellence and contributions to higher education. Alongside her academic post, she is also an investigadora adscrita at the Fundación INCLIVA, playing a dual role in both teaching and active biomedical research. Her employment reflects the seamless integration between university instruction and clinical research aimed at improving patient outcomes.

🧬 Contributions and Research Focus

Carmina Montoliu Felix has been a pivotal contributor to the field of Cellular Biology, with specific expertise in Pathology (Área 661). Since February 29, 2012, she has been classified as a Group A Researcher within the Instituto de Salud Carlos III (ISCIII) framework. Her research activities are aligned with the Programa de Estabilización de Investigadores and the Sistema Nacional de Salud (I3SNS), focusing on intensifying biomedical research and fostering translational discoveries. Her scientific work is characterized by its interdisciplinary nature and commitment to uncovering the molecular basis of diseases, contributing significantly to both national and international health research landscapes.

🏅 Accolades and Recognition

Dr. Montoliu Felix’s academic excellence has been affirmed through numerous accolades, including the Group A classification by the Comisión Técnica de Evaluación de Recursos Humanos del ISCIII, one of the highest distinctions for biomedical researchers in Spain. Her appointment as a full professor is a testament to her leadership in medical education and scientific research. She is widely recognized among her peers for her scholarly impact, rigor, and commitment to nurturing future scientists and medical professionals.

🌍 Impact and Influence

Her work not only resonates within academic circles but also extends into clinical research through her active role at INCLIVA. By integrating research and practice, Carmina Montoliu Felix exemplifies how scientific inquiry can lead to tangible health benefits. Her influence spans collaborations with national healthcare systems and academic institutions, reinforcing her role as a key figure in the biomedical field. Through platforms such as ORCID and Scopus (ORCID ID: 0000-0002-4740-4788; Scopus ID: 6701923138), her contributions are accessible globally, further amplifying her scientific impact.

🔬 Legacy and Future Contributions

With a career marked by consistent advancement and dedication to discovery, Carmina Montoliu Felix is poised to continue shaping the future of cellular pathology and biomedical research in Spain and beyond. Her dual engagement in academia and clinical research ensures that her legacy will include both scientific breakthroughs and a generation of inspired students and researchers. Looking ahead, she is expected to further expand the integration of molecular biology into clinical diagnostics, ultimately improving patient care through science.

📚 A Life Committed to Science and Society

Beyond her technical expertise and professional roles, Carmina Montoliu Felix embodies the ideals of a scholar deeply committed to the betterment of society through science. Her residence and professional base in Valencia, her continuous academic contributions, and her service within public institutions paint the portrait of a researcher who bridges the lab and the community. Through her enduring efforts, she not only advances knowledge but also enhances the collective understanding of human health and disease.

Publication

Title: Valproate Damaging Effect on Erythrocyte Metabolism as a Decisive Factor in the Development of Encephalopathy
Authors: Lyudmila Tikhonova; Eugene Maevsky; Carmina Montoliu; Elena Kosenko
Year: 2025

Title: Ammoniagenic Action of Valproate without Signs of Hepatic Dysfunction in Rats: Possible Causes and Supporting Evidence
Authors: Gubidat Alilova; Lyudmila Tikhonova; Carmina Montoliu; Elena Kosenko
Year: 2024

Title: Automatic Video-Oculography System for Detection of Minimal Hepatic Encephalopathy Using Machine Learning Tools
Authors: Alberto Calvo Córdoba; Cecilia Elisabet García Cena; Carmina Montoliu
Year: 2023

Title: Neurofilament Light Chain Protein in Plasma and Extracellular Vesicles Is Associated with Minimal Hepatic Encephalopathy and Responses to Rifaximin Treatment in Cirrhotic Patients
Authors: Alessandra Fiorillo; Juan José Gallego Roig; Franc Casanova; Amparo Urios; MP Ballester; Teresa San-Miguel; Javier Megías Vericat; Elena Kosenko; Tosca J; Maria-Pilar Rios et al.
Year: 2023

Title: Mild Cognitive Impairment Is Associated with Enhanced Activation of Th17 Lymphocytes in Non-Alcoholic Fatty Liver Disease
Authors: Alessandra Fiorillo; Juan José Gallego Roig; Franc Casanova; Carla Giménez-Garzó; Amparo Urios; MP Ballester; Lucia Durbán; Maria-Pilar Rios; Javier Megías Vericat; Teresa San-Miguel et al.
Year: 2023

Title: Erythrocytes Functionality in SARS-CoV-2 Infection: Potential Link with Alzheimer’s Disease
Authors: Elena Kosenko; Lyudmila Tikhonova; Gubidat Alilova; Carmina Montoliu
Year: 2023

Title: Plasma Extracellular Vesicles Play a Role in Immune System Modulation in Minimal Hepatic Encephalopathy
Authors: Juan José Gallego; Alessandra Fiorillo; Franc Casanova-Ferrer; Amparo Urios; MP Ballester; Lucia Durbán; Javier Megías; Teresa Rubio; Andrea Cabrera-Pastor; Desamparados Escudero-García et al.
Year: 2022

Title: Matched Paired Primary and Recurrent Meningiomas Points to Cell-Death Program Contributions to Genomic and Epigenomic Instability along Tumor Progression
Authors: Teresa San-Miguel; Javier Megías; Daniel Monleon; Lara Navarro Cerveró; Lisandra Muñoz; Carmina Montoliu; Marina Meri; Pedro Roldán; Miguel Cerdá-Nicolás; Concha López-Ginés
Year: 2022

Title: Is NMDA-Receptor-Mediated Oxidative Stress in Mitochondria of Peripheral Tissues the Essential Factor in the Pathogenesis of Hepatic Encephalopathy?
Authors: Elena Kosenko; Lyudmila Tikhonova; Gubidat Alilova; Carmina Montoliu
Year: 2022

Title: A New Score Unveils a High Prevalence of Mild Cognitive Impairment in Patients with Nonalcoholic Fatty Liver Disease
Authors: Carla Giménez-Garzó; Alessandra Fiorillo; MP Ballester; Juan José Gallego Roig; Franc Casanova-Ferrer; Amparo Urios; Salvador Benlloch; Marti-Aguado D; Teresa San-Miguel; Tosca J et al.
Year: 2021

✅ Conclusion

Carmina Montoliu Felix’s career reflects a rare blend of scientific rigor, academic leadership, and social impact. Her journey from student to full professor showcases her dedication to advancing both knowledge and healthcare. As she continues to lead research at the intersection of cellular biology and clinical application, her legacy will not only be measured in published studies and prestigious titles, but also in the real-world health outcomes and inspired minds her work cultivates. Her future contributions promise to deepen our understanding of disease and strengthen the bridge between science and society.

Nai-Bing Gu | Clinical Neuroscience | Best Researcher Award

Posted on 26/04/2025 by Neuroscientists

Prof. Dr. Nai-Bing Gu | Clinical Neuroscience | Best Researcher Award

Dr. Gu Naibing is a distinguished Chief Physician in the Department of Neurology at Xi’an Central Hospital, specializing in neuroimmunology. He has made significant contributions to the understanding of neurological diseases, particularly those related to autoimmune and inflammatory conditions of the nervous system. As a Master’s degree supervisor and an active member of several professional committees, Dr. Gu has established himself as a leader in the fields of neurology and neuroimmunology. His research, clinical expertise, and involvement in medical organizations have earned him recognition and influence in the medical community. His work continues to have a lasting impact on both the treatment of neurological diseases and the education of future healthcare professionals.

Profile

Scopus

👨‍⚕️ Early Academic Pursuits

Dr. Gu Naibing embarked on his academic journey with a keen interest in neurology and medicine. After completing his medical degree, he pursued further studies in the specialized field of neurology, which led to the completion of his Master’s degree. Throughout his academic tenure, Dr. Gu consistently demonstrated a strong dedication to advancing his understanding of complex neurological conditions. His early academic endeavors set the foundation for a career focused on improving patient outcomes and advancing scientific knowledge in neuroimmunology.

💼 Professional Endeavors

Dr. Gu Naibing has established himself as a prominent figure in the field of neurology. As a Chief Physician in the Department of Neurology at Xi’an Central Hospital, he plays a vital role in diagnosing and treating a wide range of neurological disorders. Additionally, he serves as a Master’s degree supervisor, contributing to the training and development of the next generation of medical professionals. His professional network includes multiple roles in prestigious committees, such as the Neuroimmunology Professional Committee of the Shaanxi Provincial International Medical Exchange Promotion Association and the Neurology Branch of the Xi’an Medical Association.

🔬 Contributions and Research Focus

Dr. Gu’s research primarily focuses on neuroimmunology, the intersection of the immune system and neurological diseases. His work has advanced understanding in this field, particularly with regard to the mechanisms underlying autoimmune disorders affecting the nervous system. By contributing to a deeper understanding of brain diseases, Dr. Gu’s research has had significant implications for the development of more effective treatments for patients suffering from conditions such as multiple sclerosis, encephalitis, and other neuroinflammatory disorders. His focus on integrating immunological and neurological disciplines has been pivotal in pushing the boundaries of clinical research.

🏆 Accolades and Recognition

Throughout his career, Dr. Gu Naibing has earned several accolades and recognition for his outstanding contributions to the medical field. His involvement in various professional committees highlights his leadership and influence in the realm of neurology and neuroimmunology. As a standing committee member of the Neuroimmunology Group and the Neurology Professional Committee of the Shaanxi Health Care Association, Dr. Gu’s expertise and leadership are regularly sought after. His recognition extends beyond clinical practice, as he is frequently invited to contribute to national and international discussions on neurological care and research.

🌍 Impact and Influence

Dr. Gu Naibing’s influence extends beyond his clinical and research activities. Through his active involvement in professional organizations, he has had a profound impact on the development of neurology and neuroimmunology practices in China. His leadership in committees, particularly within the Shaanxi Medical Communication Association, has helped bridge gaps between medical professionals, facilitating the exchange of ideas and research findings. His dedication to fostering collaboration among medical communities has contributed to the enhancement of healthcare practices and the overall improvement of patient care.

🧠 Legacy and Future Contributions

As Dr. Gu Naibing continues his work, his legacy in the fields of neurology and neuroimmunology will undoubtedly inspire future generations of healthcare professionals. His commitment to advancing both clinical and research practices ensures that his contributions will have a lasting impact on the treatment of neurological diseases. Looking ahead, Dr. Gu is poised to continue making significant strides in neuroimmunology, with ongoing research and collaborations aimed at developing new therapeutic approaches. His future contributions promise to further shape the landscape of neurological healthcare, enhancing the lives of patients around the world.

🌟 Final Thoughts

Dr. Gu Naibing’s career has been defined by his passion for neurology, his commitment to advancing research, and his tireless efforts to improve patient outcomes. As a clinician, educator, and researcher, he has earned the respect and admiration of his peers, contributing significantly to the advancement of medical knowledge and patient care. With his continued dedication to the field, Dr. Gu’s legacy is sure to endure, influencing both the scientific community and the generations of healthcare professionals who follow in his footsteps.

Publication

Title: Effect of BMSCs overexpressing intelectin-1 on angiogenesis in rats with cerebral infarction
Authors: B. Zhu, K. Guo, L. Zha, L. Chang, N. Gu
Year: 2025

Title: Salivary duct carcinoma presenting with unilateral multiple cranial nerve lesions and concurrent intracranial metastasis: A case report
Authors: B. Zhu, Q. Zhang, K. Guo, Y. Yang, X. Jia
Year: 2025

Conclusion

Dr. Gu Naibing’s career is a testament to his dedication to advancing the field of neurology and neuroimmunology. His groundbreaking research, leadership in medical committees, and commitment to education have shaped the future of neurological care in China. With his continued focus on improving patient care and expanding scientific knowledge, Dr. Gu is poised to make lasting contributions that will positively impact both the medical field and the lives of countless patients. His legacy will inspire future generations of researchers and clinicians in the realm of neurology.

Lin Jizhen | Cancer immunotherapy | Best Researcher Award

Posted on 12/04/202512/04/2025 by Neuroscientists

Prof. Lin Jizhen | Cancer immunotherapy | Best Researcher Award

Prof. Lin Jizhen, Union Hospital, Fujian Medical University, China.

Dr. Jizhen Lin is a distinguished physician-scientist whose career has been defined by an unwavering dedication to the field of auditory molecular biology. With his foundational medical education from Fujian Medical University and advanced research training in biochemistry and molecular biology at the University of Minnesota, he has seamlessly blended clinical acumen with scientific innovation. His professional roles have evolved from intern and research fellow to Associate Professor and Laboratory Director, reflecting a career rich in mentorship, discovery, and leadership. His research has focused extensively on otitis media and the molecular mechanisms of hearing, contributing valuable insights into the pathophysiology and potential treatments of auditory disorders.

Profile

Scopus

📚 Early Academic Pursuits

Dr. Jizhen Lin’s academic journey began with a strong foundation in medicine at Fujian Medical University, Fuzhou, China, where he earned his M.D. in 1982 and an M.S. in Otolaryngology in 1987. His thirst for advanced knowledge and scientific discovery later brought him to the University of Minnesota, Minneapolis, where he immersed himself in the fields of biochemistry and molecular biology, further enriching his expertise and setting the stage for a robust research career in auditory sciences.

🧪 Professional Endeavors

Dr. Lin’s professional path has been marked by consistent dedication and a progressive climb through academic and research positions. His early clinical exposure as an intern at Union Hospital in Fujian laid the groundwork for his subsequent transition into research. Between 1992 and 1995, he served as an International Research Fellow at the Otitis Media Research Center (OMRC), University of Minnesota. He continued to make strides as a Research Scientist and Co-director of the Otopathology-Molecular Biology Laboratory, contributing significantly to auditory molecular biology. His leadership abilities culminated in his appointment as Director of the Auditory Molecular Biology Laboratory, and he has been serving as an Associate Professor in the Department of Otolaryngology at the University of Minnesota Medical School since 2008.

🔬 Contributions and Research Focus

Throughout his career, Dr. Lin has concentrated on unraveling the complexities of auditory molecular biology with a primary focus on otitis media, a prevalent childhood disease. His contributions have been instrumental in bridging clinical otolaryngology with molecular science, employing biochemical tools to investigate the pathogenesis of auditory disorders. His laboratory has played a critical role in advancing understanding of the genetic and cellular mechanisms that underpin hearing loss and middle ear infections, particularly through innovative translational approaches.

🏅 Accolades and Recognition

Dr. Lin’s relentless pursuit of scientific excellence and impactful research has earned him widespread recognition in the field of otolaryngology. His tenure as a Graduate Faculty advisor reflects not only his dedication to mentorship but also the high regard his peers and the academic community have for his expertise. While he may not be adorned with numerous public awards, the esteem in which he is held by colleagues and students alike underscores the quiet yet profound impact of his scholarly work.

🌍 Impact and Influence

The influence of Dr. Lin’s research extends beyond the laboratory, as his findings have contributed meaningfully to clinical practices and therapeutic approaches in otolaryngology. By identifying key molecular targets and pathways involved in auditory disorders, his work continues to shape the development of novel diagnostics and treatments. Furthermore, his role in international research collaborations underscores his commitment to knowledge exchange and global scientific advancement.

🧠 Legacy and Future Contributions

Dr. Lin’s legacy is firmly rooted in the integration of molecular science with clinical otolaryngology, a field he has helped shape through decades of dedicated research and academic mentorship. As a mentor to future scientists and a contributor to critical advancements in auditory health, he remains a cornerstone in the bridge between basic science and patient care. Looking forward, his ongoing work in auditory molecular biology is poised to further uncover the mechanisms of hearing and hearing loss, promising new frontiers in medical intervention and auditory health.

🧬 Lifelong Commitment to Hearing Science

Dr. Lin’s career embodies a lifelong commitment to auditory science, from the clinic to the lab. His seamless blend of clinical knowledge, molecular expertise, and research leadership has fostered a rich legacy in otolaryngology. With ongoing contributions to scientific understanding and future discoveries on the horizon, Dr. Lin continues to inspire a generation of researchers and clinicians dedicated to improving hearing health worldwide.

Publication

Title: Cell-free transcription amplification-based split-type electrochemical sensor using enzyme-linked magnetic microbeads for minimal residual leukemia detection
Authors: Luying Yu, Jinyuan Chen, Huanjiao Weng, … Xinhua Lin, Guangxian Zhong
Year: 2025

Title: Antibody screening-assisted multichannel nanoplasmonic sensing chip based on SERS for viral screening and variants identification
Authors: Yi Liu, Huanjiao Weng, Zhiwei Chen, … Shangyuan Feng, Duo Lin
Year: 2025

Title: tRNA methyltransferase DNMT2 promotes hepatocellular carcinoma progression and enhances Bortezomib resistance through inhibiting TNFSF10
Authors: Junzhong Lai, Linqin Chen, Qiumei Li, … Jizhen Lin, Qi Chen
Year: 2025

Title: Carrimycin ameliorates lipopolysaccharide and cecal ligation and puncture-induced sepsis in mice
Authors: Junzhong Lai, Jiadi Liang, Kunsen Chen, … Qi Chen, Jizhen Lin
Year: 2024

Title: B7H3 targeting gold nanocage pH-sensitive conjugates for precise and synergistic chemo-photothermal therapy against NSCLC
Authors: Bing Chen, Kaifan Zheng, Shubin Fang, … Jizhen Lin, Xinhua Lin
Year: 2023

Title: A drug-delivery depot for epigenetic modulation and enhanced cancer immunotherapy
Authors: Junzhong Lai, Jiadi Liang, Yong Zhang, … Jizhen Lin, Qi Chen
Year: 2023

Title: Ultrasensitive detection of SARS-CoV-2 antigen using surface-enhanced Raman spectroscopy-based lateral flow immunosensor
Authors: Shuxia Lai, Yi Liu, Shubin Fang, … Jizhen Lin, Shangyuan Feng
Year: 2023

Title: Retraction Note to: Linc00210 drives Wnt/β-catenin signaling activation and liver tumor progression through CTNNBIP1-dependent manner
Authors: Xiaomin Fu, Xiaoyan Zhu, Fujun Qin, … Qinxian Zhang, Quanli Gao
Year: Not specified

Title: SFPQ Promotes Lung Cancer Malignancy via Regulation of CD44 v6 Expression
Authors: Libang Yang, Jiangbo Yang, Blake A. Jacobson, … Craig A. Henke, Jizhen Lin
Year: 2022

✅ Conclusion

Dr. Lin’s lifelong commitment to understanding the science of hearing has positioned him as a pioneering figure in otolaryngology. Through decades of research, academic guidance, and clinical collaboration, he has built a legacy rooted in translational science and patient-centered innovation. His work continues to influence both basic research and clinical practice, promising a future where auditory health is better understood and more effectively managed. As a scientist, mentor, and innovator, Dr. Lin stands as an enduring contributor to the advancement of hearing science.

Lucas Lopes | Medicina | Best Researcher Award

Posted on 26/03/2025 by Neuroscientists

Mr. Lucas Lopes | Medicina | Best Researcher Award

Mr. Lucas Lopes, Universidade de São Paulo, Faculdade de Medicina de Bauru, Brazil.

Lucas Casagrande Passoni Lopes has made significant strides in medical research, academic publishing, and global scientific collaboration. His expertise in pediatric medicine, endocrinology, and healthcare disparities has been widely recognized through his editorial leadership, peer-review contributions, and multilingual engagements. His published works address critical healthcare issues, further cementing his influence in the medical community.

Profile

Orcid

🎓 Early Academic Pursuits

Lucas Casagrande Passoni Lopes embarked on his academic journey with an unwavering passion for medicine, enrolling in the prestigious Faculdade de Medicina de Bauru at the Universidade de São Paulo, Brazil. His commitment to excellence and keen interest in pediatric and clinical research set the foundation for his future endeavors. Throughout his academic years, he demonstrated exceptional dedication, immersing himself in scientific studies and medical advancements, laying the groundwork for a promising career in healthcare and medical research.

👩‍🎓 Professional Endeavors

Beyond his medical studies, Lucas took on significant roles in the academic publishing landscape. As the In-Chief Editor of Advances in Modern Paediatrics Journal, he has played a pivotal role in shaping pediatric research dissemination. His editorial contributions extend to renowned medical journals, including Journal of Anaesthesia and Global Open Share Publishing, Clinics of Neurology, Annals of Pediatrics and Neonatal Care, and the European Journal of Cancer. Through his editorial expertise, he has facilitated the publication of groundbreaking research, furthering advancements in multiple medical disciplines.

🔬 Contributions and Research Focus

Lucas has established himself as a prolific researcher, focusing on pediatric medicine, endocrinology, and public health concerns. His notable studies include an in-depth analysis of treatments for dysmenorrhea in adolescents, published in Contemporânea – Revista de Ética e Filosofia Política, and a groundbreaking study on the underreporting of diabetes mellitus as a cause of death over 40 years in Bauru, published in Archives of Endocrinology and Metabolism. His work sheds light on critical gaps in healthcare reporting and patient management, making substantial contributions to medical literature and clinical practice.

🏆 Accolades and Recognition

Lucas’ dedication to medical research has earned him esteemed recognition within the scientific community. As an invited reviewer for numerous high-impact journals, including Current Pediatric Reviews, World Journal of Clinical Cases, International Journal of Clinical and Experimental Medical Sciences, World Journal of Gastroenterology, and Frontiers in Medicine, he has been entrusted with evaluating and shaping contemporary medical research. His expertise is widely acknowledged, with his insights influencing the peer-review process across various fields of medicine.

📚 Impact and Influence

Lucas’ influence extends far beyond his research and editorial roles. His multilingual proficiency in Portuguese, English, French, Italian, Spanish, and German allows him to engage with diverse international scientific communities, fostering cross-border collaborations. His involvement in global medical discourse ensures that cutting-edge research reaches a broader audience, ultimately contributing to the improvement of healthcare systems worldwide. His mentorship and editorial leadership have guided emerging researchers, amplifying the impact of his contributions to medical academia.

🌟 Legacy and Future Contributions

With a strong foundation in medical research and editorial expertise, Lucas continues to shape the future of pediatric and clinical medicine. His ongoing commitment to identifying healthcare disparities, advancing treatment methodologies, and supporting evidence-based medical practices positions him as a key figure in modern medical research. As he forges ahead, his contributions promise to enhance patient care, influence policy reforms, and inspire future generations of medical professionals. His legacy in scientific inquiry and knowledge dissemination will undoubtedly leave a lasting mark on the field of medicine.

publication

Title: Association between exanthematous diseases and earlier age at Type 1 diabetes diagnosis
Authors: Lucas C.P. Lopes, Lenita Zajdenverg, Rodrigo L.M. Martins, Gabriel Araujo Medeiros, Marina D. Louro, João V.M. Lanzarin, Carlos A. Negrato
Year: 2025

Title: Mortality trends from all causes and diabetes mellitus according to sex between 1998 and 2021
Authors: Carlos Antonio Negrato, Gabriel Araújo Medeiros, Giordano Bruno Duarte de Souza, Lucas Casagrande Passoni Lopes
Year: 2024

Title: Relationship between early age at menarche, older age at menopause and subtypes of breast cancer: a scoping review
Authors: Lucas Casagrande Passoni Lopes, Gabriel Araújo Medeiros, Igor José Nogueira Gualberto, Thales Baptista Gut, Rafael Vasconcelos Silva Ferrazini, Carlos Antonio Negrato
Year: 2024

Title: Association between perinatal and obstetric factors and early age at diagnosis of type 1 diabetes mellitus: a cohort study
Authors: Carlos A. Negrato, Rodrigo L. de M. Martins, Marina D. Louro, Gabriel A. Medeiros, João V.M. Lanzarin, Lenita Zajdenverg, Lucas C.P. Lopes
Year: 2024

Title: Underreporting of diabetes mellitus as the cause of death in Bauru, State of São Paulo, Brazil over 40 years: a documental study
Authors: Lucas Casagrande Passoni Lopes, Gabriel Araújo Medeiros, Mauro Wieczorek, Marina dos Santos de Carvalho Pinto, Carlos Antonio Negrato
Year: 2024

🎉 Conclusion

As a dedicated researcher, editor, and medical professional, Lucas Passoni continues to push the boundaries of medical knowledge and patient care. His contributions have not only enriched scientific literature but have also fostered meaningful discussions on global healthcare improvements. With his unwavering commitment to excellence, Lucas is poised to leave a lasting legacy in the field of medicine, inspiring future generations of researchers and practitioners alike.

Zewen Cheng | Clinical Medicine | Young Scientist Award

Posted on 11/03/202511/03/2025 by Neuroscientists

Dr. Zewen Cheng | Clinical Medicine | Young Scientist Award

Dr. Zewen Cheng, Suzhou Hospital of Integrated Traditional Chinese and Western Medicine, China.

Zewen Cheng’s career is a testament to his dedication to thoracic surgery, combining expertise in both Western and Traditional Chinese medicine. His academic excellence, professional experience, and research contributions highlight his unwavering commitment to advancing patient care. As a skilled surgeon and educator, he continues to make a significant impact in the medical community. Moving forward, his focus on innovation and mentorship will ensure that his contributions leave a lasting mark on the field of thoracic surgery, inspiring future generations of medical professionals.

Profile

Scopus

🎓 Early Academic Pursuits

Zewen Cheng embarked on his medical journey with a passion for thoracic surgery, earning a Master of Medicine in Thoracic Surgery from Soochow University in Suzhou, China. Graduating in 2019, he dedicated himself to mastering the complexities of thoracic diseases, developing a strong foundation in both clinical and surgical practices. His academic years were marked by rigorous training and an unwavering commitment to patient care, setting the stage for his future contributions to the medical field.

🏥 Professional Endeavors

After completing his degree, Zewen Cheng undertook a comprehensive three-year residency at The First Affiliated Hospital of Soochow University. From July 2019 to June 2022, he refined his expertise in thoracic surgery, gaining invaluable hands-on experience in clinical diagnostics, patient management, and surgical procedures. His tenure in the residency program enabled him to work closely with senior specialists, tackling complex cases and honing his skills. In September 2022, he advanced to the role of Attending Physician at Suzhou Hospital of Integrated Traditional Chinese and Western Medicine, where he seamlessly integrates Western and Traditional Chinese medical treatments to provide holistic patient care.

🔬 Contributions and Research Focus

Zewen Cheng is deeply invested in the evolving landscape of thoracic surgery. His research interests span innovative surgical techniques, minimally invasive procedures, and the integration of Traditional Chinese Medicine (TCM) in thoracic disease management. With proficiency in data analysis software such as R and SPSS, he actively contributes to medical research, utilizing statistical methodologies to enhance clinical decision-making. His work emphasizes the importance of interdisciplinary approaches in improving patient outcomes and advancing the field of thoracic surgery.

🏆 Accolades and Recognition

Throughout his medical career, Zewen Cheng has been recognized for his dedication and expertise in thoracic surgery. Successfully completing the standardized residency training at The First Affiliated Hospital of Soochow University, he demonstrated exceptional skill and commitment to surgical excellence. His fluency in Medical English (CET-6) has enabled him to collaborate effectively with international medical professionals, further expanding his impact within the global medical community.

💪 Impact and Influence

As an Attending Physician, Zewen Cheng plays a crucial role in supervising and training junior doctors, fostering the next generation of thoracic surgeons. His ability to blend traditional and modern medical practices ensures that patients receive comprehensive treatment tailored to their specific needs. His contributions extend beyond direct patient care, as he actively participates in multidisciplinary teams, shaping the future of thoracic surgery through collaborative innovation and knowledge sharing.

🌟 Legacy and Future Contributions

With a strong foundation in both clinical practice and research, Zewen Cheng aspires to push the boundaries of thoracic surgery through continuous learning and innovation. His commitment to integrating Traditional Chinese Medicine with contemporary surgical techniques presents new avenues for patient care and treatment efficacy. Looking ahead, he envisions contributing to groundbreaking research, refining surgical methodologies, and mentoring future medical professionals, leaving a lasting legacy in the field of thoracic surgery.

Publication

Title: Exploring the Causal Relationship Between Frailty and Chronic Obstructive Pulmonary Disease: Insights From Bidirectional Mendelian Randomization and Mediation Analysis
Authors: Zewen Cheng, Jian Wu, Chun Xu, Xiaokun Yan
Year: 2025

🏆 Conclusion

Zewen Cheng is a strong candidate for the Young Scientist Award, given his clinical expertise, innovative approach to medicine, and commitment to training future surgeons. Strengthening his research impact and expanding international collaborations would further solidify his position as a leading young scientist in thoracic surgery.

Kawthar Diab | Life Science | Best Researcher Award

Posted on 10/02/2025 by Neuroscientists

Kawthar Diab | Life Science | Best Researcher Award

Prof. Dr. Kawthar Diab, National Research Centre, Egypt.

Dr. Kawthar Abdelaziz Elsayed Mohamed Diab is a distinguished Research Professor in Genetics and Cytology at the National Research Centre, Cairo, Egypt. With a strong foundation in zoology, she pursued advanced degrees focusing on genotoxicity, cytogenetics, and medicinal plant applications in disease prevention. Her postdoctoral research at Tokai University, Japan, and the Indian Institute of Integrative Medicine, India, expanded her expertise in cancer pharmacology and bioscience. Dr. Diab has made significant contributions to genetic toxicology and the chemopreventive properties of medicinal plants, with a particular focus on the Lamiaceae family and Himalayan plants. She actively mentors Ph.D. students and collaborates on groundbreaking research projects, gaining international recognition through conferences and workshops.

Profile

Google Scholar

Scopus

🌱 Early Academic Pursuits

Kawthar Abdelaziz Elsayed Mohamed Diab embarked on her academic journey with a deep passion for zoology, earning her B.Sc. in Zoology from Al-Azhar University in 1996 with a distinguished grade of “Very Good.” She further honed her expertise by obtaining an M.Sc. in Experimental Zoology from Zagazig University in 2003, where she conducted cytogenetic and immunogenetic studies on the effects of chemotherapy drugs on reproduction. Her academic curiosity and dedication led her to pursue a Ph.D. in Zoology at Ain Shams University, awarded in 2009. Her doctoral research focused on the protective effects of medicinal plants against genotoxic damage induced by hydrocortisone in mice, marking the beginning of her lifelong commitment to genetic research and cytology.

🧬 Professional Endeavors

As a Research Professor at the Genetics and Cytology Department of the National Research Centre in Cairo, Egypt, Dr. Kawthar Diab has played a pivotal role in advancing genetic studies. Her postdoctoral fellowships further expanded her scientific horizons—first in Cancer Pharmacology at the Indian Institute of Integrative Medicine in 2012 and later in Bioscience at Tokai University, Japan, in 2014. These international research experiences enriched her expertise in genetic applications, cytogenetics, and pharmacogenomics. Her relentless pursuit of knowledge has positioned her as a leading researcher in genetic and cytological studies, bridging traditional knowledge with cutting-edge scientific advancements.

🌿 Contributions and Research Focus

Dr. Diab’s research delves into the genotoxicity of pharmaceutical compounds and the protective effects of medicinal plants. Her investigations focus on the genetic impact of chemotherapy drugs and natural therapeutic agents, particularly those derived from the Lamiaceae family, known for their biochemical and therapeutic properties. Her recent supervision of Ph.D. research on biochemical and therapeutic evaluations of medicinal plants for prostate diseases underscores her commitment to integrating molecular genetics with natural medicine. Additionally, her work on cancer chemoprevention using Himalayan plants has gained international recognition, reflecting her dedication to discovering novel plant-based remedies for serious health conditions.

🌍 Accolades and Recognition

Dr. Kawthar Diab’s expertise has been acknowledged on the global stage. She was invited as a speaker at the 6th Rajabhat University National and International Research and Academic Conference (2020), where she presented her groundbreaking research on cancer chemopreventive activity of Himalayan plants. She has also participated in esteemed international workshops, including the Fluorescence Microscopy Workshop at ICGEB, New Delhi (2019), further enhancing her methodological skills. These recognitions highlight her contributions to genetic research and her growing influence in the scientific community.

📖 Impact and Influence

Beyond her research, Dr. Diab is actively shaping the next generation of scientists. She mentors young researchers, including Ph.D. students working on innovative projects in pharmacogenomics and plant-based medicine. Her collaboration with interdisciplinary teams ensures that her work extends beyond academic publications, making real-world contributions to medical science and genetics. By fostering a culture of inquiry and scientific exploration, she continues to inspire budding researchers to explore the genetic foundations of disease prevention and treatment.

🔬 Legacy and Future Contributions

With a research portfolio spanning genetic toxicology, medicinal plant applications, and cytogenetics, Dr. Kawthar Diab’s legacy is firmly established in the scientific world. She envisions a future where genetic research and plant-based therapeutics converge to provide safer, more effective treatments for cancer and genetic disorders. Her continuous engagement with international scientific platforms and her mentorship of emerging scholars ensure that her influence will extend far beyond her own research, shaping the future of genetic and cytological studies.

Publication

Title: In Vitro Anticancer Activities of Anogeissus latifolia, Terminalia bellerica, Acacia catechu and Moringa oleifera Indian Plants
Author: KAE Diab, SK Guru, S Bhushan, AK Saxena
Year: 2015

Title: In vitro studies on phytochemical content, antioxidant, anticancer, immunomodulatory, and antigenotoxic activities of lemon, grapefruit, and mandarin citrus peels
Author: KAE Diab
Year: 2016

Title: In vivo comparative studies on antigenotoxicity of date palm (Phoenix dactylifera L.) pits extract against DNA damage induced by N-Nitroso-N-methylurea in mice
Author: KA Diab, EI Aboul-Ela
Year: 2012

Title: Carbon tetrachloride induced hepato/renal toxicity in experimental mice: antioxidant potential of Egyptian Salvia officinalis L essential oil
Author: MA Fahmy, KA Diab, NS Abdel-Samie, EA Omara, ZM Hassan
Year: 2018

Title: Genotoxicity of carbon tetrachloride and the protective role of essential oil of Salvia officinalis L. in mice using chromosomal aberration, micronuclei formation, and …
Author: KAE Diab, MA Fahmy, ZM Hassan, EM Hassan, AB Salama, EA Omara
Year: 2018

Title: Inhibitory activity of black mulberry (Morus nigra) extract against testicular, liver and kidney toxicity induced by paracetamol in mice
Author: KA Diab, MA Fahmy, EM Hassan, ZM Hassan, EA Omara, …
Year: 2020

Title: The impact of the low frequency of the electromagnetic field on human
Author: KA Diab
Year: 2020

Title: Inhibitory activity of flaxseed oil against CdCl2 induced liver and kidney damage: Histopathology, genotoxicity, and gene expression study
Author: KA Diab, NE Ibrahim, MA Fahmy, EM Hassan, EA Omara
Year: 2020

🏆 Conclusion

Dr. Kawthar Diab’s journey from an aspiring zoologist to a distinguished Research Professor in Genetics and Cytology is a testament to her unwavering commitment to scientific discovery. Her work not only enhances our understanding of genetic toxicology but also paves the way for integrating traditional medicinal knowledge with modern genetic research. As she continues to push the boundaries of genetic science, her contributions remain invaluable to both academia and global health advancements.

Zhiyong Hou | Trauma related neurological injury | Best Researcher Award

Posted on 14/10/202414/10/2024 by Neuroscientists

Dr.Zhiyong Hou | Trauma related neurological injury | Best Researcher Award

Dr. Zhiyong Hou Hebei Medical University Third Hospital China

Dr. Zhiyong Hou is a distinguished medical professional and leader in the field of orthopedics, holding multiple prestigious positions including Dean of the Surgery Department and President of the 3rd Hospital at Hebei Medical University. With an extensive academic background, he has published over 200 scientific articles, authored numerous patents, and contributed to multiple medical journals as an editor and reviewer. Dr. Hou has received significant national recognition, including various awards for his contributions to medical science and technology. His involvement in medical societies and educational programs highlights his commitment to advancing the field of orthopedics, particularly in trauma and innovative surgical techniques.

profile

google scholar

🏥 Professional Status

Dean of Surgery Department, Hebei Medical University.President of the 3rd Hospital of Hebei Medical University.Professor of Hebei Medical University.Senior Director of Orthopedic Department of the 3rd Hospital of Hebei Medical University.Professor of Changjiang Scholar Program from the National Ministry ofEducation.Candidates for the National Million Talents Project.State Council Special Allowance Expert.Director of the Orthopedic Minimum Invasive Device Education Research Center from the National Ministry of Education.Adviser for Post Doctoral, Doctoral, and Master Degree Programs at Hebei Medical University.Director of National Advanced Professional and Technical Team.Director of Innovative Orthopedic Team of Hebei Medical University.Extraordinary Talent of Hebei Province.Outstanding Professional of Hebei Province

🩺 Medical Societies

Vice Chairman of the Chinese Medical Association Trauma Division.Vice Chairman of the Chinese Medical Association Orthopedic Division.

👩‍⚕️ Youth Committee

Chairman of the Chinese Medical Doctor Association Orthopedic Division Youth Committee.Member of the Orthopaedic Trauma Association (OTA).Standing Committee Member of the SICOT World Congress Chinese TraumaDivision.Orthopaedic Fellow at the Geisinger Medical Center in the US

🏆 Distinctions

Second Prize of National Technical Invention Award.Two Second Prizes of National Science and Technology Progress Award.Three First Prizes for Scientific and Technological Progress in Hebei Province.Top 10 National Best Young Orthopedic Professionals of the Chinese Medical Doctor Association.Young Experts with Outstanding National Contributions.Wu Jieping-Paul Janssen Medical & Pharmaceutical Award.National May 1st Labour Day Medal.Three First Prizes for the Chinese Medical Science and Technology Award.Awarded National Key R&D Plan Funding.Awarded General Projects of the National Natural Science Foundation of China.

📖 Scientific Journals

Associate Chief Editor of the Journal of Chinese Traumatic Orthopaedics.Associate Editor of BMC Musculoskeletal Disorders.Associate Editor of Orthopedic Surgery and Traumatology.Associate Editor of the Frontiers in Surgery.Lead Guest Editor of Biomed Research International.Member of the Reviewer Committee for various international journals.

📚 Academic Research and Publications

Published more than 200 SCI-indexed scientific journals, with 96 as First Author or Corresponding Author.More than 20 patents as First Inventor.Published 10 books as Chief Editor or Associate Editor

📚 Publications

Title: Medial compartment decompression by fibular osteotomy to treat medial compartment knee osteoarthritis: a pilot study
Authors: ZY Yang, W Chen, CX Li, J Wang, DC Shao, ZY Hou, SJ Gao, F Wang, …
Year: 2015

Title: Intertrochanteric femur fracture treatment in Asia: what we know and what the world can learn
Authors: SM Chang, ZY Hou, SJ Hu, SC Du
Year: 2020

Title: Delayed flap reconstruction with vacuum-assisted closure management of the open IIIB tibial fracture
Authors: Z Hou, K Irgit, KA Strohecker, ME Matzko, NC Wingert, JG DeSantis, …
Year: 2011

Title: Acute compartment syndrome: Cause, diagnosis, and new viewpoint
Authors: J Guo, Y Yin, L Jin, R Zhang, Z Hou, Y Zhang
Year: 2019

Title: Epidemiologic characteristics of traumatic fractures in elderly patients during the outbreak of coronavirus disease 2019 in China
Authors: Y Zhu, W Chen, X Xin, Y Yin, J Hu, H Lv, W Li, X Deng, C Zhu, J Zhu, …
Year: 2020

Title: Epidemiologic characteristics of traumatic fractures during the outbreak of coronavirus disease 2019 (COVID-19) in China: A retrospective & comparative multi-center study
Authors: H Lv, Q Zhang, Y Yin, Y Zhu, J Wang, Z Hou, Y Zhang, W Chen
Year: 2020

Title: Negative-pressure therapy versus conventional therapy on split-thickness skin graft: a systematic review and meta-analysis
Authors: Y Yin, R Zhang, S Li, J Guo, Z Hou, Y Zhang
Year: 2018

Title: Treatment of pertrochanteric fractures (OTA 31-A1 and A2): long versus short cephalomedullary nailing
Authors: Z Hou, TR Bowen, KS Irgit, ME Matzko, CM Andreychik, DS Horwitz, …
Year: 2013

Title: Locked plating of periprosthetic femur fractures above total knee arthroplasty
Authors: Z Hou, TR Bowen, K Irgit, K Strohecker, ME Matzko, J Widmaier, …
Year: 2012

Title: A occult and regular combination injury: the posterior malleolar fracture associated with spiral tibial shaft fracture
Authors: Z Hou, Q Zhang, Y Zhang, S Li, J Pan, H Wu
Year: 2009

Title: Treatment of interprosthetic fractures of the femur
Authors: Z Hou, B Moore, TR Bowen, K Irgit, ME Matzko, KA Strohecker, WR Smith
Year: 2011

Conclusion

Dr. Zhiyong Hou’s impressive credentials and achievements underscore his pivotal role in the advancement of orthopedic medicine in China and beyond. His leadership positions and active participation in various medical societies demonstrate his dedication to fostering innovation and excellence in healthcare. Through his research, mentorship, and contributions to medical literature, Dr. Hou continues to influence the future of orthopedic practices, making a lasting impact on patient care and medical education.